PHARMACEUTICALLY ACCEPTABLE SALTS OF MESDOPETAM AND USES THEREOF

A method for the prevention or reduction of sensitization to a pharmaceutical drug for Parkinson's disease, the method comprising administering to a subject in need thereof a therapeutically effective amount of a compound of Formula I,or a pharmaceutically acceptable salt thereof.A method for t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Holm Waters, Susanna, Svenningsson, Per, Tedroff, Joakim Mihkel
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Holm Waters, Susanna
Svenningsson, Per
Tedroff, Joakim Mihkel
description A method for the prevention or reduction of sensitization to a pharmaceutical drug for Parkinson's disease, the method comprising administering to a subject in need thereof a therapeutically effective amount of a compound of Formula I,or a pharmaceutically acceptable salt thereof.A method for the optimization of the dosage of a pharmaceutical drug for Parkinson's disease, the method comprising administering to a subject in need thereof a therapeutically effective amount of a compound of Formula I or a pharmaceutically acceptable salt thereof.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2022168242A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2022168242A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2022168242A13</originalsourceid><addsrcrecordid>eNrjZHAI8HAM8nV0dg0N8XR29PGJVHB0dnYNCHF08nFVCHb0CQlW8HdT8HUNdvEPcA1x9FVw9HNRCA12DVYI8XANcvV342FgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8aHBRgZGRoZmFkYmRo6GxsSpAgBX0iuM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PHARMACEUTICALLY ACCEPTABLE SALTS OF MESDOPETAM AND USES THEREOF</title><source>esp@cenet</source><creator>Holm Waters, Susanna ; Svenningsson, Per ; Tedroff, Joakim Mihkel</creator><creatorcontrib>Holm Waters, Susanna ; Svenningsson, Per ; Tedroff, Joakim Mihkel</creatorcontrib><description>A method for the prevention or reduction of sensitization to a pharmaceutical drug for Parkinson's disease, the method comprising administering to a subject in need thereof a therapeutically effective amount of a compound of Formula I,or a pharmaceutically acceptable salt thereof.A method for the optimization of the dosage of a pharmaceutical drug for Parkinson's disease, the method comprising administering to a subject in need thereof a therapeutically effective amount of a compound of Formula I or a pharmaceutically acceptable salt thereof.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220602&amp;DB=EPODOC&amp;CC=US&amp;NR=2022168242A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220602&amp;DB=EPODOC&amp;CC=US&amp;NR=2022168242A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Holm Waters, Susanna</creatorcontrib><creatorcontrib>Svenningsson, Per</creatorcontrib><creatorcontrib>Tedroff, Joakim Mihkel</creatorcontrib><title>PHARMACEUTICALLY ACCEPTABLE SALTS OF MESDOPETAM AND USES THEREOF</title><description>A method for the prevention or reduction of sensitization to a pharmaceutical drug for Parkinson's disease, the method comprising administering to a subject in need thereof a therapeutically effective amount of a compound of Formula I,or a pharmaceutically acceptable salt thereof.A method for the optimization of the dosage of a pharmaceutical drug for Parkinson's disease, the method comprising administering to a subject in need thereof a therapeutically effective amount of a compound of Formula I or a pharmaceutically acceptable salt thereof.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHAI8HAM8nV0dg0N8XR29PGJVHB0dnYNCHF08nFVCHb0CQlW8HdT8HUNdvEPcA1x9FVw9HNRCA12DVYI8XANcvV342FgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8aHBRgZGRoZmFkYmRo6GxsSpAgBX0iuM</recordid><startdate>20220602</startdate><enddate>20220602</enddate><creator>Holm Waters, Susanna</creator><creator>Svenningsson, Per</creator><creator>Tedroff, Joakim Mihkel</creator><scope>EVB</scope></search><sort><creationdate>20220602</creationdate><title>PHARMACEUTICALLY ACCEPTABLE SALTS OF MESDOPETAM AND USES THEREOF</title><author>Holm Waters, Susanna ; Svenningsson, Per ; Tedroff, Joakim Mihkel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2022168242A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2022</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Holm Waters, Susanna</creatorcontrib><creatorcontrib>Svenningsson, Per</creatorcontrib><creatorcontrib>Tedroff, Joakim Mihkel</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Holm Waters, Susanna</au><au>Svenningsson, Per</au><au>Tedroff, Joakim Mihkel</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PHARMACEUTICALLY ACCEPTABLE SALTS OF MESDOPETAM AND USES THEREOF</title><date>2022-06-02</date><risdate>2022</risdate><abstract>A method for the prevention or reduction of sensitization to a pharmaceutical drug for Parkinson's disease, the method comprising administering to a subject in need thereof a therapeutically effective amount of a compound of Formula I,or a pharmaceutically acceptable salt thereof.A method for the optimization of the dosage of a pharmaceutical drug for Parkinson's disease, the method comprising administering to a subject in need thereof a therapeutically effective amount of a compound of Formula I or a pharmaceutically acceptable salt thereof.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2022168242A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title PHARMACEUTICALLY ACCEPTABLE SALTS OF MESDOPETAM AND USES THEREOF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T22%3A23%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Holm%20Waters,%20Susanna&rft.date=2022-06-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2022168242A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true